Human Genome Sciences, Inc.Rockville, MD United States
Company Description
Human Genome Sciences (HGS) knows that the path to good health starts at the molecular level. Using its expertise in human genetics, the biopharmaceutical discovery and development firm is working on therapies for infectious and autoimmune diseases, cardiovascular disease, and cancer. In 2011 lead candidate Benlysta gained FDA approval to treat systemic lupus. Previously, the company's only product approved for sale was an antibody treatment for inhaled anthrax. Benlysta was developed through a partnership with
| 14200 Shady Grove Rd. | Phone: 301-309-8504 | http://www.hgsi.com |
| Rockville, MD 20850 | Fax: 301-309-8512 | 
Map This Company |
| United States |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
Human Genome Sciences, Inc. Rankings
Executives
| 80 executives listed for Human Genome Sciences, Inc.'s Rockville, MD location. | ||
| Chairman | Argeris Karabelas | |
|---|---|---|
| President, CEO, and Director | H. Thomas Watkins | |
| SVP Operations | Curran Simpson | |
Financials
| Company Type | Public - NASDAQ: HGSI Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 1,100 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Human Genome Sciences, Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
